Asymmetrical Dimethylarginine: The Über Marker?

Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease

Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,584 · see citing works

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107 · see citing works

Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction

Suwaidi, J. M. S. A., Hamasaki, S., Higano, S. T., Nishimura, R. A., Holmes, D. R., & Lerman, A. (2000) · Circulation · doi:10.1161/01.cir.101.9.948 · Cited by 2,044 · see citing works

Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors

Vásquez-Vivar, J., Kalyanaraman, B., Martásek, P., Hogg, N., Masters, B. S. S., Karoui, H., Tordo, P., & Pritchard, K. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9220 · Cited by 1,484 · see citing works

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction: Its Role in Hypercholesterolemia

Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181 · see citing works

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087 · see citing works

Predictive value of noninvasivelydetermined endothelial dysfunction for long-term cardiovascular events inpatients with peripheral vascular disease

Gokce, N., Keaney, J. F., Hunter, L. M., Watkins, M. T., Nedeljkovic, Z. S., Menzoı́an, J. O., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00333-4 · Cited by 776 · see citing works

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

von der Leyen, H. E., Gibbons, G. H., Morishita, R., Lewis, N. P., Zhang, L., Nakajima, M., Kaneda, Y., Cooke, J. P., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1137 · Cited by 763 · see citing works

Endogenous Nitric Oxide Synthase Inhibitor

Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756 · see citing works

NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease

Cooke, J. P., & Dzau, V. J. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.489 · Cited by 710 · see citing works

Superoxide Generation from Endothelial Nitric-oxide Synthase

Xia, Y., Tsai, A.-L., Berka, V., & Zweier, J. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25804 · Cited by 705 · see citing works

Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.

Cooke, J. P., Singer, A. H., Tsao, P. S., Zera, P. H., Rowan, R. A., & Billingham, M. E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115937 · Cited by 687 · see citing works

Homocysteine Impairs the Nitric Oxide Synthase Pathway

Stuehlinger, M., Tsao, P. S., Her, J. H., Kimoto, M., Balint, R. F., & Cooke, J. P. (2001) · Circulation · doi:10.1161/hc4601.098514 · Cited by 662 · see citing works

Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus

Lin, K. Y., Ito, A., Asagami, T., Tsao, P. S., Adimoolam, S., Kimoto, M., Tsuji, H., Reaven, G. M., & Cooke, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000027109.14149.67 · Cited by 651 · see citing works

Accelerated Atherosclerosis, Aortic Aneurysm Formation, and Ischemic Heart Disease in Apolipoprotein E/Endothelial Nitric Oxide Synthase Double-Knockout Mice

Kuhlencordt, P. J., Gyurko, R., Han, F., Scherrer‐Crosbie, M., Aretz, T. H., Hajjar, R. J., Picard, M. H., & Huang, P. L. (2001) · Circulation · doi:10.1161/hc2901.091399 · Cited by 631 · see citing works

Novel Mechanism for Endothelial Dysfunction

Ito, A., Tsao, P. S., Adimoolam, S., Kimoto, M., Ogawa, T., & Cooke, J. P. (1999) · Circulation · doi:10.1161/01.cir.99.24.3092 · Cited by 629 · see citing works

Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase

Achan, V., Broadhead, M., Malaki, M., Whitley, G. S. J., LEIPER, J. M., MacAllister, R. J., & Vallance, P. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000081742.92006.59 · Cited by 593 · see citing works

Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor

Stuehlinger, M. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581 · see citing works

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

Valkonen, V.-P., Päivä, H., Salonen, J. T., Lakka, T. A., Lehtimäki, T., Laakso, J., & Laaksonen, R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07184-7 · Cited by 562 · see citing works

Oxidized Low-density Lipoprotein Decreases the Expression of Endothelial Nitric Oxide Synthase

Liao, J. K., Shin, W. S., Lee, W. Y., & Clark, S. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.319 · Cited by 541 · see citing works

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

Savvidou, M. D., Hingorani, A. D., Tsikas, D., Frölich, J. C., Vallance, P. J., & Nicolaides, K. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13177-7 · Cited by 515 · see citing works

Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive Disease

Böger, R. H., Bode‐Böger, S. M., Thiele, W., Junker, W., Alexander, K., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.95.8.2068 · Cited by 490 · see citing works

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

LEIPER, J. M., MARIA, J. S., Chubb, A., MacAllister, R. J., Charles, I. G., Whitley, G. S. J., & Vallance, P. J. (1999) · Biochemical Journal · doi:10.1042/bj3430209 · Cited by 478 · see citing works

LDL Cholesterol Upregulates Synthesis of Asymmetrical Dimethylarginine in Human Endothelial Cells

Böger, R. H., Sydow, K., Borlak, J. T., Thum, T., Lenzen, H., Schubert, B., Tsikas, D., & Bode‐Böger, S. M. (2000) · Circulation Research · doi:10.1161/01.res.87.2.99 · Cited by 478 · see citing works

A Caveolar Complex between the Cationic Amino Acid Transporter 1 and Endothelial Nitric-oxide Synthase May Explain the “Arginine Paradox”

McDonald, K., Zharikov, S. I., Block, E. R., & Kilberg, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31213 · Cited by 436 · see citing works

ADMA and oxidative stress

Sydow, K., & Münzel, T. F. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00033-3 · Cited by 431 · see citing works

Reduced Urinary Excretion of Nitric Oxide Metabolites and Increased Plasma Levels of Asymmetric Dimethylarginine in Men with Essential Hypertension

Surdacki, A., Nowicki, M. P., Sandmann, J., Tsikas, D., Boeger, R. H., Bode-Boeger, S. M., Kruszelnicka-Kwiatkowska, O., Kokot, F., Dubiel, J. S., & Froelich, J. C. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199904000-00020 · Cited by 422 · see citing works

Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase

MacAllister, R. J., Parry, H., Kimoto, M., Ogawa, T., Russell, R. J., Hodson, H. F., Whitley, G. S. J., & Vallance, P. J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16069.x · Cited by 394 · see citing works

Gene therapy inhibiting neointimal vascular lesion

Leyen, V. D. (1995) · Medical Entomology and Zoology · Cited by 386 · see citing works

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

Abbasi, F., Asagmi, T., Cooke, J. P., Lamendola, C. A., McLaughlin, T., Reaven, G. M., Stuehlinger, M., & Tsao, P. S. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02063-x · Cited by 354 · see citing works

Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis

Dayoub, H., Achan, V., Adimoolam, S., Jacobi, J., Stuehlinger, M. C., Wang, B., Tsao, P. S., Kimoto, M., Vallance, P. J., Patterson, A. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000101924.04515.2e · Cited by 340 · see citing works

Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine.

Tsao, P. S., McEvoy, L. M., Drexler, H., Butcher, E. C., & Cooke, J. P. (1994) · Circulation · doi:10.1161/01.cir.89.5.2176 · Cited by 324 · see citing works

Association of the Missense Glu298Asp Variant of the Endothelial Nitric Oxide Synthase Gene With Myocardial Infarction

Shimasaki, Y., Yasue, H., Yoshimura, M., Nakayama, M., Kugiyama, K., Ogawa, H., Harada, E., Masuda, T., Koyama, W., Saito, Y., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00167-3 · Cited by 316 · see citing works

The DDAH/ADMA/NOS pathway

Tran, C. T. L., LEIPER, J. M., & Vallance, P. J. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00032-1 · Cited by 315 · see citing works

Asymmetric Dimethylarginine, C-Reactive Protein, and Carotid Intima-Media Thickness in End-Stage Renal Disease

Zoccali, C., Benedetto, F. A., Maas, R., Mallamaci, F., Tripepi, G. L., Malatino, L., & Diaeresis]ger, R. B. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132490 · Cited by 315 · see citing works

Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia

Stuehlinger, M., Oka, R. K., Graf, E. E., Schmoelzer, I., Upson, B. M., Kapoor, O., Szuba, A., Malinow, M. R., Wascher, T. C., Pachinger, O. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000085067.55901.89 · Cited by 303 · see citing works

Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction

嶋崎, 幸. (1999) · Medical Entomology and Zoology · doi:10.11501/3166056 · Cited by 292 · see citing works

S -nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: Further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

LEIPER, J. M., Murray‐Rust, J., McDonald, N. Q., & Vallance, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212269799 · Cited by 288 · see citing works

NO and angiogenesis

Cooke, J. P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00034-5 · Cited by 266 · see citing works

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

Böger, R. H., Bode‐Böger, S. M., Thiele, W., Creutzig, A., Alexander, K., & Frölich, J. C. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00375-1 · Cited by 263 · see citing works

Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial

Engler, M. M., Engler, M. B., Malloy, M. J., Chiu, E. Y., Schloetter, M. C., Paul, S. M., Stuehlinger, M., Lin, K. Y., Cooke, J. P., Morrow, J. D., et al. (2003) · Circulation · doi:10.1161/01.cir.0000086345.09861.a0 · Cited by 253 · see citing works

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality

Nijveldt, R. J. (2003) · Clinical Nutrition · doi:10.1054/clnu.2002.0613 · Cited by 252 · see citing works

Study on the Relationship Between Plasma Nitrite and Nitrate Level and Salt Sensitivity in Human Hypertension: Modulation of Nitric Oxide Synthesis by Salt Intake

Fujiwara, N., Osanai, T., Kamada, T., Katoh, T., Takahashi, K., & Okumura, K. (2000) · Circulation · doi:10.1161/01.cir.101.8.856 · Cited by 242 · see citing works

Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine

Lundman, P., Eriksson, M. J., Stuehlinger, M., Cooke, J. P., Hamsten, A., & Tornvall, P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01318-3 · Cited by 236 · see citing works

Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure

Usui, M., Matsuoka, H., Miyazaki, H., Ueda, S., Okuda, S., & Imaizumi, T. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00225-2 · Cited by 232 · see citing works

An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes

Böger, R. H., Bode‐Böger, S. M., Tsao, P. S., Lin, P. S., Chan, J. R., & Cooke, J. P. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01013-5 · Cited by 227 · see citing works

Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes

Fard, A., Tuck, C. H., Donis, J. A., Sciacca, R. R., Tullio, M. R. D., Wu, H. D., Bryant, T. A., Chen, N.-T., Torres‐Tamayo, M., Ramasamy, R., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.9.2039 · Cited by 221 · see citing works

Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase.

Murray‐Rust, J., LEIPER, J. M., McAlister, M. S. B., Phelan, J. P., Tilley, S. J., MARIA, J. S., Vallance, P. J., & McDonald, N. Q. (2001) · Nature Structural Biology · doi:10.1038/90387 · Cited by 217 · see citing works

Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients

Zoccali, C., Mallamaci, F., Maas, R., Benedetto, F. A., Tripepi, G. L., Malatino, L., Cataliotti, A., Bellanuova, I., Böger, R. H., & on behalf of the CREED INVESTIGATORS (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00437.x · Cited by 213 · see citing works

Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke

Yoo, J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00444-0 · Cited by 210 · see citing works

Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects

Kielstein, J. T., Bode‐Böger, S. M., Frölich, J. C., Ritz, E., Haller, H. G., & Fliser, D. (2003) · Circulation · doi:10.1161/01.cir.0000060496.23144.a7 · Cited by 210 · see citing works

Short-term Oral Administration of l- Arginine Improves Hemodynamics and Exercise Capacity in Patients with Precapillary Pulmonary Hypertension

Nagaya, N., Uematsu, M., Oya, H., Sato, N., Sakamaki, F., Kyotani, S., Ueno, K., Nakanishi, N., Yamagishi, M., & Miyatake, K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.4.2007116 · Cited by 200 · see citing works

Studies on the catabolism of NG-methylarginine, NG, NG-dimethylarginine and NG, NG-dimethylarginine in the rabbit

MCDERMOTT, J. R. (1976) · Biochemical Journal · doi:10.1042/bj1540179 · Cited by 194 · see citing works

Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia

Holden, D. P., Fickling, S. A., Whitley, G. S. J., & Nussey, S. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70437-5 · Cited by 181 · see citing works

Oral l-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease

Adams, M. R., McCredie, R. J., Jessup, W., Robinson, J. T. C., SULLIVAN, D. R., & Celermajer, D. S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06044-3 · Cited by 181 · see citing works

Regression or Progression

Candipan, R. C., Wang, B., Buitrago, R., Tsao, P. S., & Cooke, J. P. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.1.44 · Cited by 180 · see citing works

Short-term Pulmonary Vasodilation With l -Arginine in Pulmonary Hypertension

Mehta, S., Stewart, D. J., Langleben, D., & Levy, R. D. (1995) · Circulation · doi:10.1161/01.cir.92.6.1539 · Cited by 177 · see citing works

Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery.

Weidinger, F. F., McLenachan, J. M., Cybulsky, M. I., Gordon, J. B., Rennke, H. G., Hollenberg, N. K., Fallon, J. T., Ganz, P., & Cooke, J. P. (1990) · Circulation · doi:10.1161/01.cir.81.5.1667 · Cited by 174 · see citing works

Dietary l-Arginine Supplementation Normalizes Platelet Aggregation in Hypercholesterolemic Humans

Wolf, A., Zalpour, C., Theilmeier, G., Wang, B., Ma, A. O., Anderson, B. E., Tsao, P. S., & Cooke, J. P. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00523-8 · Cited by 171 · see citing works

Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes

Asagami, T., Abbasi, F., Stuelinger, M., Lamendola, C. A., McLaughlin, T., Cooke, J. P., Reaven, G. M., & Tsao, P. S. (2002) · Metabolism · doi:10.1053/meta.2002.33349 · Cited by 164 · see citing works

Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer’s disease

Selley, M. L. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00007-1 · Cited by 159 · see citing works

Plasma Levels of Asymmetrical Dimethyl-l-Arginine in Patients with Congenital Heart Disease and Pulmonary Hypertension

Gorenflo, M., Zheng, C., Werle, E., Fiehn, W., & Ulmer, H. E. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200104000-00016 · Cited by 150 · see citing works

Cytomegalovirus Infection Impairs the Nitric Oxide Synthase Pathway

Weis, M., Kledal, T. N., Lin, K. Y., Panchal, S. N., Gao, S., Valantine, H. A., Mocarski, E. S., & Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000109692.16004.af · Cited by 149 · see citing works

all- trans -Retinoic Acid Increases Nitric Oxide Synthesis by Endothelial Cells

Achan, V., Tran, C. T. L., Arrigoni, F., Whitley, G. S. J., LEIPER, J. M., & Vallance, P. J. (2002) · Circulation Research · doi:10.1161/01.res.0000014450.40853.2b · Cited by 147 · see citing works

Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG, NG-dimethylarginine in human essential hypertension1

Delles, C., Schneider, M. P., John, S., Gekle, M., & Schmieder, R. E. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02278-1 · Cited by 141 · see citing works

Asymmetric Dimethylarginine Increases Mononuclear Cell Adhesiveness in Hypercholesterolemic Humans

Chan, J. R., Böger, R. H., Bode‐Böger, S. M., Tangphao, O., Tsao, P. S., Blaschke, T. F., & Cooke, J. P. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.1040 · Cited by 140 · see citing works

Angiogenesis Is Impaired by Hypercholesterolemia

Jang, J. J., Ho, H. –. V., Kwan, H. H., Fajardo, L. F., & Cooke, J. P. (2000) · Circulation · doi:10.1161/01.cir.102.12.1414 · Cited by 133 · see citing works

Metabolism of Asymmetric Dimethylarginines Is Regulated in the Lung Developmentally and With Pulmonary Hypertension Induced by Hypobaric Hypoxia

Arrigoni, F., Vallance, P. J., Haworth, S. G., & LEIPER, J. M. (2003) · Circulation · doi:10.1161/01.cir.0000051466.00227.13 · Cited by 133 · see citing works

L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits.

Tsao, P. S., Theilmeier, G., Singer, A. H., Leung, L. L. K., & Cooke, J. P. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1529 · Cited by 127 · see citing works

Evidence for Dysregulation of Dimethylarginine Dimethylaminohydrolase I in Chronic Hypoxia–Induced Pulmonary Hypertension

Millatt, L. J., Whitley, G. S. J., Li, D., LEIPER, J. M., Siragy, H. M., Carey, R. M., & Johns, R. A. (2003) · Circulation · doi:10.1161/01.cir.0000089087.25930.ff · Cited by 123 · see citing works

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients

Fleck, C., Janz, A., Schweitzer, F., Karge, E., Schwertfeger, M., & Stein, G. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780014.x · Cited by 119 · see citing works

Estrogen Stimulates Dimethylarginine Dimethylaminohydrolase Activity and the Metabolism of Asymmetric Dimethylarginine

Holden, D. P., Cartwright, J. E., Nussey, S., & Whitley, G. S. J. (2003) · Circulation · doi:10.1161/01.cir.0000091083.61609.df · Cited by 117 · see citing works

Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina

Walker, H. A., McGing, E., Fisher, I. B., Böger, R. H., Bode‐Böger, S. M., Jackson, G., Ritter, J. M., & Chowienczyk, P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01380-8 · Cited by 112 · see citing works

Renin-Angiotensin System is Involved in the Mechanism of Increased Serum Asymmetric Dimethylarginine in Essential Hypertension.

Ito, A., Egashira, K., Narishige, T., Muramatsu, K., & Takeshita, A. (2001) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.65.775 · Cited by 102 · see citing works

Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan‐induced hyperglycaemia

Masuda, H., Goto, M., Tamaoki, S., & Azuma, H. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702298 · Cited by 99 · see citing works

Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study

Saran, R. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg406 · Cited by 92 · see citing works

Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis

Kostourou, V., Robinson, S. P., Cartwright, J. E., & Whitley, G. S. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600518 · Cited by 90 · see citing works

Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women

Teerlink, T., Neele, S. J. M., de Jong, S., Netelenbos, J. C., & Stehouwer, C. D. A. (2003) · Clinical Science · doi:10.1042/cs20020309 · Cited by 61 · see citing works

Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure

Kielstein, J. T., Bode‐Böger, S. M., Klein, G. G., Graef, S., Haller, H. G., & Fliser, D. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01149.x · Cited by 60 · see citing works

Effect of Hormone Replacement Therapy on Plasma Levels of the Cardiovascular Risk Factor Asymmetric Dimethylarginine: A Randomized, Placebo-Controlled 12-Week Study in Healthy Early Postmenopausal Women

Post, M. S., Verhoeven, M. O., van der Mooren, M. J., Kenemans, P., Stehouwer, C. D. A., & Teerlink, T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030584 · Cited by 58 · see citing works

Heat shock protein 90 and tyrosine kinase regulate eNOS NO· generation but not NO· bioactivity

Ou, J., Fontana, J. T., Ou, Z., Jones, D. W., Ackerman, A. W., Oldham, K. T., Yu, J., Sessa, W. C., & Pritchard, K. A. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00736.2003 · Cited by 53 · see citing works

Effect of local delivery of l-arginine on in-stent restenosis in humans

Suzuki, T., Hayase, M., Hibi, K., Hosokawa, H., Yokoya, K., Fitzgerald, P. J., Yock, P. G., Cooke, J. P., Suzuki, T., & Yeung, A. C. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02252-4 · Cited by 32 · see citing works

Endogenous Nitric Oxide Synthase Inhibitors in Endothelial Cells, Endothelin-1 Within the Vessel Wall, and Intimal Hyperplasia in Perimenopausal Human Uterine Arteries

Beppu, M., Obayashi, S., Asô, T., Goto, M., & Azuma, H. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200202000-00005 · Cited by 27 · see citing works

Plasma concentration of asymmetric dimethylarginine and the risk of coronary heart disease: rationale and design of the multicenter CARDIAC study

Mügge, A., Hanefeld, C., & Böger, R. H. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00031-x · Cited by 17 · see citing works

Chronic Kidney Disease: Effects on the Cardiovascular System

Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448 · see citing works

Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?

Rehman, K., & Akash, M. S. H. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0303-y · Cited by 685 · see citing works

Pharmacokinetic and pharmacodynamic properties of oral L‐citrulline and L‐arginine: impact on nitric oxide metabolism

Schwedhelm, E., Maas, R., Freese, R., Jung, D., Lukacs, Z., Jambrecina, A., Spickler, W., Schulze, F., & Böger, R. H. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02990.x · Cited by 494 · see citing works

Nitric oxide and atherosclerosis: An update

Claudio Napoli, A., de Nigris, F., Williams‐Ignarro, S., Pignalosa, O., Sica, V., & Ignarro, L. J. (2006) · Nitric Oxide · doi:10.1016/j.niox.2006.03.011 · Cited by 463 · see citing works

Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses

Fernández-Macías, J. C., Ochoa-Martínez, A. C., Varela-Silva, J. A., & Pérez-Maldonado, I. N. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.08.009 · Cited by 458 · see citing works

Biomarkers in chronic kidney disease: a review

Fassett, R. G., Venuthurupalli, S. K., Gobe, G. C., Coombes, J. S., Cooper, M. A., & Hoy, W. E. (2011) · Kidney International · doi:10.1038/ki.2011.198 · Cited by 449 · see citing works

Disruption of methylarginine metabolism impairs vascular homeostasis

LEIPER, J. M., Nandi, M., Torondel, B., Murray‐Rust, J., Malaki, M., O'Hara, B. P., Rossiter, S., Anthony, S., Madhani, M., Selwood, D. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1543 · Cited by 403 · see citing works

Asymmetrical Dimethylarginine Predicts Progression to Dialysis and Death in Patients with Chronic Kidney Disease

Ravani, P., Tripepi, G. L., Malberti, F., Testa, S., Mallamaci, F., & Zoccali, C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010076 · Cited by 375 · see citing works

Symmetric dimethylarginine (SDMA) as endogenous marker of renal function–a meta-analysis

Kielstein, J. T., Salpeter, S. R., Bode-Boeger, S. M., Cooke, J. P., & Fliser, D. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl292 · Cited by 363 · see citing works

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

Shah, N. H., LePendu, P., Bauer‐Mehren, A., Ghebremariam, Y. T., Iyer, S. V., Marcus, J. R., Nead, K. T., Cooke, J. P., & Leeper, N. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124653 · Cited by 332 · see citing works

Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease

Fliser, D., Kronenberg, F., Kielstein, J. T., Morath, C. P., Bode‐Böger, S. M., Haller, H. G., & Ritz, E. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020179 · Cited by 310 · see citing works

Symmetrical Dimethylarginine

Bode‐Böger, S. M., Scalera, F., Kielstein, J. T., Martens‐Lobenhoffer, J., Breithardt, G. D., Fobker, M., & Reinecke, H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101119 · Cited by 300 · see citing works

Asymmetric Dimethylarginine, L-Arginine, and Endothelial Dysfunction in Essential Hypertension

Perticone, F., Sciacqua, A., Maio, R., Perticone, M., Maas, R., Böger, R. H., Tripepi, G., Sesti, G., & Zoccali, C. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.040 · Cited by 269 · see citing works

Unexpected Effect of Proton Pump Inhibitors

Ghebremariam, Y. T., LePendu, P., Lee, J. C., Erlanson, D. A., Slaviero, A., Shah, N. H., LEIPER, J. M., & Cooke, J. P. (2013) · Circulation · doi:10.1161/circulationaha.113.003602 · Cited by 258 · see citing works

Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay

Schulze, F., Wesemann, R., Schwedhelm, E., Sydow, K., Albsmeier, J., Cooke, J. P., & Böger, R. H. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.257 · Cited by 252 · see citing works

Olive Oil Polyphenols Decrease Blood Pressure and Improve Endothelial Function in Young Women with Mild Hypertension

Moreno‐Luna, R., Múñoz‐Hernández, R., Miranda, M. L., Costa, A. F., Jiménez-Jiménez, L., Vallejo‐Vaz, A. J., Muriana, F. J. G., Villar, J. R., & Stiefel, P. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.128 · Cited by 243 · see citing works

<scp>l</scp> -Arginine Supplementation in Peripheral Arterial Disease: No Benefit and Possible Harm

Wilson, A. M., Harada, R., Nair, N., Balasubramanian, N., & Cooke, J. P. (2007) · Circulation · doi:10.1161/circulationaha.106.683656 · Cited by 241 · see citing works

Acute Effects of High-Fat Meals Enriched With Walnuts or Olive Oil on Postprandial Endothelial Function

Cortés, B., Núñez, I., Cofán, M., Gilabert, R., Pérez-Heras, A., Casals, E., Deulofeu, R., & Ros, E. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.057 · Cited by 239 · see citing works

Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond

Böger, R. H. (2006) · Annals of Medicine · doi:10.1080/07853890500472151 · Cited by 236 · see citing works

Asymmetrical Dimethylarginine Independently Predicts Total and Cardiovascular Mortality in Individuals with Angiographic Coronary Artery Disease (The Ludwigshafen Risk and Cardiovascular Health Study)

Meinitzer, A., Seelhorst, U., Wellnitz, B., Halwachs‐Baumann, G., Boehm, B. O., Winkelmann, B. R., & März, W. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.076711 · Cited by 227 · see citing works

Association of Oxidative Stress, Insulin Resistance, and Diabetes Risk Phenotypes

Meigs, J. B., Larson, M. G., Fox, C. S., Keaney, J. F., Vasan, R. S., & Benjamin, E. J. (2007) · Diabetes Care · doi:10.2337/dc07-0817 · Cited by 220 · see citing works

The role of obesity in preeclampsia

Roberts, J. M., Bodnar, L. M., Patrick, T. E., & Powers, R. W. (2010) · Pregnancy Hypertension · doi:10.1016/j.preghy.2010.10.013 · Cited by 205 · see citing works

The Deleterious Effects of Hyperglycemia on Platelet Function in Diabetic Patients With Acute Coronary Syndromes

Worthley, M. I., Holmes, A. S., Willoughby, S. R., Kucia, A. M., Heresztyn, T., Stewart, S., Chirkov, Y. Y., Zeitz, C. J., & Horowitz, J. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.053 · Cited by 188 · see citing works

Vascular Incompetence in Dialysis Patients—Protein‐Bound Uremic Toxins and Endothelial Dysfunction

Jourde‐Chiche, N., Dou, L., Cérini, C., Dignat‐George, F., & Brunet, P. (2011) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2011.00925.x · Cited by 186 · see citing works

Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study

Schulze, F., Lenzen, H., Hanefeld, C., Bartling, A., Osterziel, K. J., Goudeva, L., Schmidt‐Lucke, C., Kusus, M., Maas, R., Schwedhelm, E., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.06.005 · Cited by 185 · see citing works

ADMA metabolism and clearance

Teerlink, T. (2005) · Vascular Medicine · doi:10.1191/1358863x05vm597oa · Cited by 184 · see citing works

Resveratrol Reverses Endothelial Nitric-Oxide Synthase Uncoupling in Apolipoprotein E Knockout Mice

Xia, N., Daiber, A., Habermeier, A., Closs, E. I., Thum, T., Spanier, G., Lü, Q., Oelze, M. W., Torzewski, M., Lackner, K. J., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168724 · Cited by 183 · see citing works

Adverse Effects of Cigarette Smoke on NO Bioavailability

Zhang, W., Venardos, K. M., Chin-Dusting, J. P. F., & Kaye, D. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000231509.27406.42 · Cited by 180 · see citing works

Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension

Pullamsetti, S. S., Kiss, L., Ghofrani, H. A., Voswinckel, R., Haredza, P., Klepetko, W., Aigner, C., Fink, L., Muyal, J. P., Weißmann, N., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3223fje · Cited by 177 · see citing works

Asymmetric Dimethylarginine: A Cardiovascular Risk Factor and a Uremic Toxin Coming of Age?

Kielstein, J. T., & Zoccali, C. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.05.009 · Cited by 171 · see citing works

Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis

Gritters, M., Grooteman, M. P. C., Schoorl, M. G., Schoorl, M., Bartels, P. C. M., Scheffer, P. G., Teerlink, T., Schalkwijk, C. G., Spreeuwenberg, M. D., & Nubé, M. J. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi069 · Cited by 163 · see citing works

HPLC analysis of ADMA and other methylated l-arginine analogs in biological fluids

Teerlink, T. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.07.024 · Cited by 155 · see citing works

Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System

Li, H., & Förstermann, U. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789058002 · Cited by 149 · see citing works

Upregulation of Endothelial and Inducible Nitric Oxide Synthase Expression by Reactive Oxygen Species

Zhen, J., Lu, H., Wang, X. Q., Vaziri, N. D., & Zhou, X. J. (2007) · American Journal of Hypertension · doi:10.1038/ajh.2007.14 · Cited by 147 · see citing works

Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis

Schulz, R., Rassaf, T., Massion, P. B., Kelm, M., & Balligand, J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.005 · Cited by 146 · see citing works

Soluble RAGE in type 2 diabetes: Association with oxidative stress

Devangelio, E., Santilli, F., Formoso, G., Ferroni, P., Bucciarelli, L. G., Michetti, N., Clissa, C., Ciabattoni, G., Consoli, A., & Davı̀, G. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.015 · Cited by 145 · see citing works

Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes

Schepers, E., Glorieux, G., Dhondt, A., Leybaert, L., & Vanholder, R. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn670 · Cited by 145 · see citing works

Decreased Exhaled Nitric Oxide in Pulmonary Arterial Hypertension

Girgis, R. E., Champion, H. C., Diette, G. B., Johns, R. A., Permutt, S., & SYLVESTER, J. T. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200412-1684oc · Cited by 144 · see citing works

Depression, heart rate related variables and cardiovascular disease

Taylor, C. B. (2010) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2010.04.006 · Cited by 143 · see citing works

Symmetric Dimethylarginine as a Proinflammatory Agent in Chronic Kidney Disease

Schepers, E., Barreto, D. V., Liabeuf, S., Glorieux, G., Eloot, S., Barreto, F. C., Massy, Z. A., & Vanholder, R. C. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01720211 · Cited by 143 · see citing works

Overexpression of Dimethylarginine Dimethylaminohydrolase Reduces Tissue Asymmetric Dimethylarginine Levels and Enhances Angiogenesis

Jacobi, J., Sydow, K., von Degenfeld, G., Zhang, Y., Dayoub, H., Wang, B., Patterson, A. J., Kimoto, M., Blau, H. M., & Cooke, J. P. (2005) · Circulation · doi:10.1161/01.cir.0000158487.80483.09 · Cited by 143 · see citing works

Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction

Fujii, H., Goto, S., & Fukagawa, M. (2018) · Toxins · doi:10.3390/toxins10050202 · Cited by 142 · see citing works

Asymmetric Dimethylarginine Independently Predicts Fatal and Nonfatal Myocardial Infarction and Stroke in Women

Leong, T., Zylberstein, D. E., Graham, I. M., Lissner, L., Ward, D., Fogarty, J., Bengtsson, C., Björkelund, C., & Thelle, D. S. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.156596 · Cited by 141 · see citing works

High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using HPLC-MS/MS

Midttun, Ø., Kvalheim, G., & Ueland, P. M. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6602-6 · Cited by 137 · see citing works

Brachial Artery Flow-Mediated Dilation and Asymmetrical Dimethylarginine in the Cardiovascular Risk in Young Finns Study

Juonala, M., Viikari, J. S. A., Alfthan, G., Marniemi, J., Kähönen, M. A. P., Taittonen, L. M., Laitinen, T. T., & Raitakari, O. T. (2007) · Circulation · doi:10.1161/circulationaha.107.690016 · Cited by 133 · see citing works

Oleuropein: A natural antioxidant molecule in the treatment of metabolic syndrome

Ahamad, J., Toufeeq, I., Khan, M. A., Ameen, M. S. M., Anwer, E. T., Uthirapathy, S., Mir, S. R., & Ahmad, J. (2019) · Phytotherapy Research · doi:10.1002/ptr.6511 · Cited by 133 · see citing works

Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD

Mallamaci, F., Tripepi, G. L., Cutrupi, S., Malatino, L., & Zoccali, C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00338.x · Cited by 132 · see citing works

Update on the Pharmacokinetics and Redox Properties of Protein-Bound Uremic Toxins

Watanabe, H., Miyamoto, Y., Otagiri, M., & Maruyama, T. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22592 · Cited by 131 · see citing works

Microcirculation and oxidative stress

Crimi, E., Ignarro, L. J., & Claudio Napoli, A. (2007) · Free Radical Research · doi:10.1080/10715760701732830 · Cited by 121 · see citing works

Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials

Böger, R. H. (2005) · Vascular Medicine · doi:10.1177/1358836x0501000104 · Cited by 120 · see citing works

Anti‐Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis

Rashidi, B., Hoseini, Z. S., Sahebkar, A., & Mirzaei, H. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25738 · Cited by 118 · see citing works

Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium

Ding, H., & Triggle, C. R. (2005) · Vascular Health and Risk Management · doi:10.2147/vhrm.1.1.55.58939 · Cited by 118 · see citing works

The Clinical Significance of Asymmetric Dimethylarginine

Siroen, M. P. C., Teerlink, T., Nijveldt, R. J., Prins, H. A., Richir, M. C., & van Leeuwen, P. A. M. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111320 · Cited by 115 · see citing works

Fast and Efficient Determination of Arginine, Symmetric Dimethylarginine, and Asymmetric Dimethylarginine in Biological Fluids by Hydrophilic-Interaction Liquid Chromatography–Electrospray Tandem Mass Spectrometry

Martens‐Lobenhoffer, J., & Bode‐Böger, S. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.060152 · Cited by 113 · see citing works

L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.

Böger, R. H., & Ron, E. S. (2005) · PubMed · Cited by 112 · see citing works

Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA)

Maas, R. (2005) · Vascular Medicine · doi:10.1191/1358863x05vm605oa · Cited by 112 · see citing works

Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA

Sydow, K., Mondon, C. E., & Cooke, J. P. (2005) · Vascular Medicine · doi:10.1177/1358836x0501000106 · Cited by 112 · see citing works

Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor

Cooke, J. P. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.01.061 · Cited by 110 · see citing works

Endometriosis: Perspective, lights, and shadows of etiology

Asghari, S., Valizadeh, A., Maleki, L. A., Nouri, M., & Yousefi, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.109 · Cited by 110 · see citing works

Aspirin reduces endothelial cell senescence

Bode‐Böger, S. M., Martens‐Lobenhoffer, J., Täger, M., Schröder, H., & Scalera, F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.014 · Cited by 110 · see citing works

Symmetrical and Asymmetrical Dimethylarginine as Predictors for Mortality in Patients Referred for Coronary Angiography: The Ludwigshafen Risk and Cardiovascular Health Study

Meinitzer, A., Kielstein, J. T., Pilz, S., Drechsler, C., Ritz, E., Boehm, B. O., Winkelmann, B. R., & März, W. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.150854 · Cited by 104 · see citing works

Dimethylarginine Dimethylaminohydrolase Overexpression Suppresses Graft Coronary Artery Disease

Tanaka, M., Sydow, K., Gunawan, F., Jacobi, J., Tsao, P. S., Robbins, R. C., & Cooke, J. P. (2005) · Circulation · doi:10.1161/circulationaha.105.537670 · Cited by 103 · see citing works

Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis

Elesber, A. A., Solomon, H., Lennon, R. J., Mathew, V., Prasad, A., Pumper, G. M., Nelson, R. E., McConnell, J. P., Lerman, L. O., & Lerman, A. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi749 · Cited by 103 · see citing works

Dimethylarginine Dimethylaminohydrolase Overexpression Enhances Insulin Sensitivity

Sydow, K., Mondon, C. E., Schrader, J., Konishi, H., & Cooke, J. P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.162073 · Cited by 102 · see citing works

Short-term physical inactivity impairs vascular function

Nosova, E. V., Yen, P. K., Chong, K. C., Alley, H. F., Stock, E. O., Quinn, A., Hellmann, J. L., Conte, M. S., Owens, C. D., Spite, M. R., et al. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.02.001 · Cited by 95 · see citing works

Erythropoietin Increases Asymmetric Dimethylarginine in Endothelial Cells

Scalera, F., Kielstein, J. T., Martens‐Lobenhoffer, J., Postel, S. C., Diaeresis]ger, M. T., & Bode‐Böger, S. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090735 · Cited by 95 · see citing works

Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events

Krempl, T. K., Maas, R., Sydow, K., Meinertz, T., Böger, R. H., & Kahler, J. P. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi287 · Cited by 93 · see citing works

Predictors of Cardiovascular Death in ESRD

Zoccali, C., Tripepi, G. L., & Mallamaci, F. (2005) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2005.05.002 · Cited by 92 · see citing works

Psychophysiological and Cortisol Responses to Psychological Stress in Depressed and Nondepressed Older Men and Women With Elevated Cardiovascular Disease Risk

Taylor, C. B., Conrad, A., Wilhelm, F. H., Neri, E., DeLorenzo, A., Kramer, M. A., Giese‐Davis, J., Roth, W. T., Oka, R. K., Cooke, J. P., et al. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000222372.16274.92 · Cited by 91 · see citing works

Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases

Łuczak, A., Madej, M., Kasprzyk, A., & Doroszko, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1417981 · Cited by 90 · see citing works

Atherosclerosis and Oxidant Stress: The End of the Road for Antioxidant Vitamin Treatment?

Thomson, M. J. C. B., Püntmann, V. O., & Kaski, J. C. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6027-1 · Cited by 89 · see citing works

Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants

Speer, P. D., Powers, R. W., Frank, M. P., Harger, G. F., Marković, N., & Roberts, J. M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.05.052 · Cited by 88 · see citing works

Long‐term use of proton pump inhibitors, dose–response relationship and associated risk of ischemic stroke and myocardial infarction

Sehested, T. S. G., Gerds, T. A., Fosbøl, E. L., Hansen, P. W., Charlot, M. G., Carlson, N., Hlatky, M. A., Torp-Pedersen, C. T., & Gislason, G. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12698 · Cited by 84 · see citing works

Overexpression of Dimethylarginine Dimethylaminohydrolase Inhibits Asymmetric Dimethylarginine–Induced Endothelial Dysfunction in the Cerebral Circulation

Dayoub, H., Rodionov, R. N., Lynch, C. M., Cooke, J. P., Arning, E., Bottiglieri, T., Lentz, S. R., & Faraci, F. M. (2007) · Stroke · doi:10.1161/strokeaha.107.490631 · Cited by 82 · see citing works

Asymmetric Dimethylarginine Determines the Improvement of Endothelium-Dependent Vasodilation by Simvastatin

Böger, G. I., Rudolph, T. K., Maas, R., Schwedhelm, E., Dumbadze, E., Bierend, A., Benndorf, R. A., & Böger, R. H. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.051 · Cited by 80 · see citing works

AGXT2: a promiscuous aminotransferase

Rodionov, R. N., Jarzebska, N., Weiss, N., & Lentz, S. R. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.005 · Cited by 79 · see citing works

Cross-sectional associations between physical activity and selected coronary heart disease risk factors in young adults. The Cardiovascular Risk in Young Finns Study

Mansikkaniemi, K., Juonala, M., TAIMELA, S. P., Hirvensalo, M. H., Telama, R., Huupponen, R., Saarikoski, L. A., Hurme, M., Mallat, Z., Bénessiano, J., et al. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.590146 · Cited by 79 · see citing works

Kidney dysfunction in patients with pulmonary arterial hypertension

Nickel, N. P., O’Leary, J. M., Brittain, E. L., Fessel, J. P., Zamanian, R. T., West, J. D., & Austin, E. D. (2016) · Pulmonary Circulation · doi:10.1086/690018 · Cited by 78 · see citing works

Chromatographic-mass spectrometric methods for the quantification of l-arginine and its methylated metabolites in biological fluids

Martens‐Lobenhoffer, J., & Bode‐Böger, S. M. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.07.038 · Cited by 75 · see citing works

Effect of Telmisartan on Nitric Oxide–Asymmetrical Dimethylarginine System

Scalera, F., Martens‐Lobenhoffer, J., Bukowska, A., Lendeckel, U., Täger, M., & Bode‐Böger, S. M. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.104570 · Cited by 73 · see citing works

Diabetes, obesity, and erectile dysfunction

Tamler, R. (2009) · Gender Medicine · doi:10.1016/j.genm.2008.12.003 · Cited by 72 · see citing works

Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance

Teerlink, T. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.197 · Cited by 72 · see citing works

Asymmetric Dimethylarginine and Reduced Nitric Oxide Bioavailability in Young Black African Men

Melikian, N., Wheatcroft, S. B., Ogah, O. S., Murphy, C., Chowienczyk, P., Wierzbicki, A. S., Sanders, T. A. B., Jiang, B., Duncan, E. R., Shah, A. M., et al. (2007) · Hypertension · doi:10.1161/01.hyp.0000258405.25330.80 · Cited by 70 · see citing works

Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events

Penka, M., Rajković, M. G., Steiner, S., Strasser, B., Ziegler, S., Zorn, G., Maurer, G., Simeon-Rudolf, V., Wojta, J., Huber, K., et al. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-03-0158 · Cited by 69 · see citing works

Asymmetric dimethylarginine (ADMA): the silent transition from an ‘uraemic toxin’ to a global cardiovascular risk molecule

Fliser, D. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01457.x · Cited by 69 · see citing works

Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease

Wilson, A., Shin, D. S., Weatherby, C., Harada, R. K., Ng, M. K., Nair, N., Kielstein, J. T., & Cooke, J. P. (2010) · Vascular Medicine · doi:10.1177/1358863x10364552 · Cited by 67 · see citing works

Structure of the Mammalian NOS Regulator Dimethylarginine Dimethylaminohydrolase: A Basis for the Design of Specific Inhibitors

Frey, D., Braun, O., Briand, C., Vašák, M., & Grütter, M. G. (2006) · Structure · doi:10.1016/j.str.2006.03.006 · Cited by 67 · see citing works

Pathogenic Cycle Between the Endogenous Nitric Oxide Synthase Inhibitor Asymmetrical Dimethylarginine and the Leukocyte-Derived Hemoprotein Myeloperoxidase

von Leitner, E.-C., Klinke, A., Atzler, D., Slocum, J. L., Lund, N., Kielstein, J. T., Maas, R., Schmidt-Haupt, R., Pekarová, M., Hellwinkel, O., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.060541 · Cited by 66 · see citing works

Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move

Zoccali, C. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000217839.26971.8d · Cited by 66 · see citing works

Effects of ADMA upon Gene Expression: An Insight into the Pathophysiological Significance of Raised Plasma ADMA

Smith, C. L., Anthony, S., Hubank, M. J. F., LEIPER, J. M., & Vallance, P. J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020264 · Cited by 66 · see citing works

Simultaneous quantitative determination of NG,NG-dimethyl-l-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry

Gangi, I. M. D., Chiandetti, L., Gucciardi, A., Moret, V., Naturale, M., & Giordano, G. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2010.08.011 · Cited by 65 · see citing works

Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality

Böger, R. H., Maas, R., Schulze, F., & Schwedhelm, E. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.196 · Cited by 65 · see citing works

Dimethylarginine Dimethylaminohydrolase Overexpression Ameliorates Atherosclerosis in Apolipoprotein E-Deficient Mice by Lowering Asymmetric Dimethylarginine

Jacobi, J., Maas, R., Cardounel, A. J., Arend, M., Pope, A. J., Cordasic, N., Heusinger‐Ribeiro, J., Atzler, D., Strobel, J., Schwedhelm, E., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090614 · Cited by 63 · see citing works

Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease

Kielstein, J. T., & Zoccali, C. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328314b6ca · Cited by 62 · see citing works

Aerobic Exercise Training Decreases Plasma Asymmetric Dimethylarginine Concentrations With Increase in Arterial Compliance in Postmenopausal Women

Tanahashi, K., Akazawa, N., Miyaki, A., Choi, Y., Ra, S., Matsubara, T., Kumagai, H., Oikawa, S., & Maeda, S. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt217 · Cited by 61 · see citing works

Androgen Deficiency and Endothelial Dysfunction in Men with End-Stage Kidney Disease Receiving Maintenance Hemodialysis

Karakitsos, D., Patrianakos, A. P., de Groot, E., Boletis, J., Karabinis, A., Kyriazis, J., Samonis, G., Parthenakis, F. I., Vardas, P. E., & Daphnis, E. K. (2006) · American Journal of Nephrology · doi:10.1159/000097816 · Cited by 61 · see citing works

Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in vitro Evaluation

Schepers, E., Glorieux, G., Dou, L., Cérini, C., Gayrard, N., Louvet, L., Maugard, C., Preus, P., Rodríguez-Ortiz, M. E., Argilés, À., et al. (2010) · Blood Purification · doi:10.1159/000320765 · Cited by 60 · see citing works

Quantification of l-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: A step improvement in precision by stable isotope dilution mass spectrometry

Martens‐Lobenhoffer, J., & Bode‐Böger, S. M. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.07.021 · Cited by 60 · see citing works

Nitric oxide and reactive oxygen species in limb vascular function: what is the effect of physical activity?

Gliemann, L., Nyberg, M., & Hellsten, Y. (2013) · Free Radical Research · doi:10.3109/10715762.2013.835045 · Cited by 59 · see citing works

ADMA, C-Reactive Protein, and Albuminuria in Untreated Essential Hypertension: A Cross-sectional Study

Tsioufis, C. P., Dimitriadis, K. S., Andrikou, E., Thomopoulos, C., Tsiachris, D., Stefanadi, E., Mihas, C. C., Miliou, A., Papademetriou, V., & Stefanadis, C. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.11.024 · Cited by 58 · see citing works

Asymmetric Dimethylarginine and Atherosclerosis

Qin, J. (2003) · Advances in Cardiovascular Diseases

Asymmetric Dimethylarginine and Cerebrovascular Disorders in Humans

Tsuda, K. (2006) · Stroke · doi:10.1161/01.str.0000248209.76578.3a

Original Article Handling of asymmetrical dimethylarginine and symmetrical

Nijveldt, R. J., Teerlink, T., Guldener, C. V., Prins, H. A., van Lambalgen, A. A., Stehouwer, C. D. A., Rauwerda, J. A., & van Leeuwen, P. A. M. (2015)

Do Homoarginine and Asymmetric Dimethylarginine Act Antagonistically in the Cardiovascular System?

Tsikas, D., & Kayacelebi, A. A. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0484 · Cited by 35 · see citing works

Abstract 4054: Determinants of Circulating Asymmetric Dimethylarginine, Monomethylarginine and L-Arginine: A Population-Based Study

Chirinos, J. A., Lezama, J. M., David, R., Bralley, J. A., Vargas, O. L. M., Zea-Díaz, H., Bolaños, J., Valdivia-Ascuña, Z., Diaz, S. P., Medina, F. F. C., et al. (2006) · Circulation